Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ropivacaine Wound Infusion in Spine Surgery
NCT01743794Phase 3Completed
- Sponsor
- CHU Grenoble Alpes
- Start
- Jan 2011
- Primary completion
- Jan 2011
- Modality
- Targeted Liposomes, Stealth (PEGylated) Liposomes, Conventional Liposomes
- Countries
- 1
01
Overview
A Phase 3 trial of ropivacaine hydrochloride liposomal suspension injection in postoperative pain, sponsored by CHU Grenoble Alpes. Started Jan 2011; status: completed.
02
Drugs
ropivacaine hydrochloride liposomal suspension injection
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT01743794.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01743794.